Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Apply
BT5528
A Study of Nuzefatide Pevedotin (BT5528) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step